NCT00172003View on ClinicalTrials.gov

Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Renal Cell CancerNeoplasm Metastasis
Interventions
DRUG

Zoledronic acid

Trial Locations (1)

Unknown

Novartis investigative Site, Offenbach

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY